Cascade Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Feb 11, 2026
Total Funding Raised
$91.4M
Company Overview
Cascade Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes innovative drugs targeting nuclear receptors and G protein-coupled receptors (GPCRs) for metabolic diseases and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cascade Pharmaceuticals, Inc. Comps
Public and private peers based on sector, stage, and business model.
Cascade Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 11, 2026 | ||||
| Early Funding | Feb 10, 2026 | ||||
| Series A | Aug 11, 2023 |
Cascade Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Guoxin Venture | VC Round |
| China Life Capital | VC Round |
| Shanghai Guotou Pioneer Private Equity Fund Management | Early Funding |
| Guokejiahe Fund | Series A |
| PWC Capital | Series A |
| Zhongping Capital | VC Round, Early Funding |
| SDIC Venture Capital | VC Round |
Cascade Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cascade Pharmaceuticals, Inc.'s valuation, stock price, and market status.
